Home/Filings/4/0001104659-25-087055
4//SEC Filing

Hahn Mark W 4

Accession 0001104659-25-087055

CIK 0001657312other

Filed

Sep 2, 8:00 PM ET

Accepted

Sep 3, 4:30 PM ET

Size

5.2 KB

Accession

0001104659-25-087055

Insider Transaction Report

Form 4
Period: 2025-08-29
Hahn Mark W
Chief Financial Officer
Transactions
  • Gift

    Ordinary Shares

    2025-08-291,200,00011,264,968 total
Footnotes (2)
  • [F1]Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
  • [F2]Consists of (i) 2,375,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 296,875 ADSs); and (ii) 8,889,968 Ordinary Shares underlying 1,111,246 ADSs.

Issuer

Verona Pharma plc

CIK 0001657312

Entity typeother

Related Parties

1
  • filerCIK 0001408502

Filing Metadata

Form type
4
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 4:30 PM ET
Size
5.2 KB